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Abstract
Aims We hypothesized that grading of diastolic dysfunction (DDF) according to two DDF grading algorithms and strain im-
aging yields prognostic information on all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF).
Methods and results We enrolled ambulatory HFrEF (left ventricular ejection fraction < 45%; N = 1 065) patients who
underwent echocardiography and speckle tracking assessment of global longitudinal strain (GLS). Patients were stratified ac-
cording to DDF grades (Grades I–III) according to two contemporary DDF grading algorithms. Prognostic performance was
assessed by C-statistics. Of the originally 1 065 enrolled patients, a total of 645 (61%) patients (age: 67 ± 11 years, male:
72%, ejection fraction: 27 ± 9%) were classified according to both DDF grading algorithms. Concordance between the algo-
rithms was moderate (kappa = 0.48) and the reclassification rate was 33%. During a median follow-up of 3.3 years (1.9, 4.7
years), 101 (16%) died from all causes. When comparing DDF Grade I vs. Grade III, both algorithms provided prognostic infor-
mation [Nagueh: (hazard ratio) HR 2.09, 95% confidence interval (CI),1.32–3.31, P = 0.002; Johansen: HR 2.47, 95% CI, 1.57–
3.87, P < 0.001]. However, when comparing DDF Grade II vs. Grade III, only the Johansen algorithm yielded prognostic infor-
mation (Nagueh: HR 1.04, 95% CI, 0.60–1.77, P = 0.90; Johansen: HR 2.26, 95% CI, 1.35–3.77, P = 0.002). We found no differ-
ence in prognostic performance between the two algorithms (C-statistics: 0.604 vs. 0.623, P = 0.24). Assessed by C-statistics,
the most powerful predictors of the endpoint from the two algorithms were E/e’-ratio (C-statistics: 0.644), tricuspid regurgi-
tation velocity (C-statistics: 0.625) and E/A-ratio (C-statistics: 0.602). When adding GLS to a combination of these predictors,
the prognostic performance increased significantly (C-statistics: 0.705 vs. C-statistics: 0.634, P = 0.028).
Conclusions Evaluation of DDF in patients with HFrEF yields prognostic information on all-cause mortality. Furthermore,
adding GLS to contemporary algorithms of DDF adds novel prognostic information.
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Introduction
Approximately 50% of patients with congestive heart failure
(HF) do not exhibit left ventricular (LV) systolic dysfunction.1
Studies have suggested that these patients suffer from HF
caused by LV diastolic dysfunction (DDF) and have increased
LV filling pressures.2,3 Hence, DDF is recognized as a para-
mount entity in the HF syndrome. Several prognostic markers
have been examined in HF with reduced ejection fraction
(HFrEF), however, the prognostic role of DDF in HFrEF pa-
tients is poorly investigated.4 Recently, studies have indicated
that assessment of strain parameters, involving global
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longitudinal strain (GLS), may correlate with LV filling pres-
sure.5 Despite GLS commonly is linked to systolic function, it
may be reduced in patients with HF with preserved ejection
fraction (HFpEF), and furthermore, studies have argued that
longitudinal deformation should be regarded as a determi-
nant of diastolic function.6,7 Based on this, GLS may poten-
tially offer guidance on grading of DDF in HFrEF patients.8
The guideline for echocardiographic assessment of DDF
was recently updated by the American Society of Echocardi-
ography and the European Association of Cardiovascular Im-
aging. This guideline suggests that the ratio between peak
transmitral early (E) and late (A) diastolic inflow velocity
(E/A-ratio) should be the initial step in evaluating DDF in
HFrEF. By contrast, a recent study proposed that average
peak early diastolic mitral annular velocity (e’) was a more
precise parameter to evaluate impaired LV relaxation.9 Con-
sidering that assessment of DDF mostly relies upon empiri-
cally derived cut-off values and consensus statements, only
few studies have investigated and compared algorithms for
classification of DDF with outcome.
The aim of the present study was to evaluate echocardio-
graphic classification of DDF in HFrEF patients according to
two contemporary algorithms and to investigate the prognos-
tic potential for all-cause mortality. We hypothesized that in-
creasing degree of DDF, as assessed in each algorithm, was
associated with a worse prognosis. Furthermore, we hypoth-
esized that GLS offers novel information on grading of DDF
and adds prognostic information to grading of DDF in patients
with HFrEF.
Methods
Study population
This was a retrospective study of 1 102 nonacute patients re-
ferred to the HFrEF clinic at Gentofte University Hospital, Co-
penhagen, Denmark. Upon referral, all patients had a LV
ejection fraction (LVEF) of 45% or less. Baseline clinical data
including medical history and previous cardiac procedures
were collected at first visit in the clinic, and we retrospec-
tively assessed this from electronic medical records. The diag-
nosis of HFrEF was given by an experienced clinician. A cross
reference with the hospital’s echocardiographic database
allowed us to retrieve echocardiographic examinations. Pa-
tients were included if their echocardiographic examination
was performed at a maximum of 1 year from the first admit-
tance [median 30 days before admittance; interquartile range
(IQR) 6, 56 days]. All echocardiograms were conducted from
December 2005 to July 2013. We excluded patients who
had no echocardiogram performed within 1 year of the first
admittance (N = 22), poor image quality or inadequate echo-
cardiography (N = 15), atrial fibrillation/flutter (N = 172), no
assessment of E/A (N = 29), and e’ (N = 42). Additionally,
we excluded 119 patients who were classified as normal by
Johansen et al., 51 patients who were categorized as indeter-
minate by Nagueh et al. and seven patients who were
deemed both normal and indeterminate by the two algo-
rithms. A total of 645 patients were eligible for analysis (Fig-
ure 1). The study was approved by the Danish Data Protection
Agency (j: 03240, GEH-2014-047) and complied with the Dec-
laration of Helsinki.
Echocardiography
The echocardiographic examinations were performed using
Vivid 7 or 9 machines (GE Healthcare, Little Chalfont, United
Kingdom). A GE Healthcare image vault was used for storing
the images. All images were then analyzed offline using
EchoPac version 12 (GE Healthcare) by a single investigator
blinded to all baseline data.
Conventional Echocardiography
The Simpson’s biplane method was used to assess LVEF.10 LV
end-diastolic measures, including interventricular septum
thickness, LV posterior wall dimension, and LV internal di-
mension, were measured in the parasternal long-axis view
at the tip of mitral valve leaflets.10 The Devereux formula
was used to estimate LV mass.11 Accordingly, the LV mass in-
dex was calculated as LV mass divided by body surface area.
The area length method was used to measure the left atrial
volume, and the left atrial volume index (LAVI) was obtained
by dividing with body surface area.12 We also calculated pa-
rameters of minimum and maximum LAVI. In the apical
four-chamber view, the tricuspid annular plane systolic excur-
sion was measured using M-mode echocardiography. The mi-
tral valve inflow pattern was measured using pulsed-wave
Doppler imaging in the apical four-chamber view and used
to obtain the peak velocities of early (E) and late (A) diastolic
LV filling. From these, the E/A-ratio was calculated and decel-
eration time of the E-wave was measured. In the apical four-
chamber view, by use of the continuous wave Doppler imag-
ing, tricuspid regurgitation (TR) velocity was determined. By
use of tissue Doppler imaging (TDI), the peak longitudinal
early diastolic (e’) tissue velocity was measured with the sam-
ple volume placed at the septal and lateral mitral annular
sites in the apical four-chamber view. The mean value was
calculated as the average of the lateral and septal velocities.
The ratio between E-wave and e’ (E/e’) was then calculated
to assess the LV filling pressure.13 Mitral regurgitation was
classified as mild/moderate/severe according to the clinician
performing the echocardiographic examination.
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Diastolic dysfunction classification
We categorized all patients according to two contemporary
algorithms of DDF.
Algorithm by Nagueh et al. (Figure 2A)
The initial step included evaluation of the E/A-ratio and E-
wave. If the E/A-ratio was ≤0.8 and E > 50 cm/s or E/A-ratio
was between 0.8 and 2.0, three parameters had to be evalu-
ated. These parameters were (i) E/e’-ratio > 14, (ii) TR veloc-
ity > 2.8 m/s, and (iii) LAVI > 34 mL/m2. If two or three of
these criteria were negative, patients were assigned as having
DDF Grade I (N = 407). If two or three of these were positive,
patients had DDF Grade II (N = 102). When patients only had
two of the above-mentioned parameters available, two nega-
tive criteria were categorized as DDF Grade I, two positives as
DDF Grade II, and one positive and one negative as indeter-
minate. If the E/A-ratio was ≥ 2.0, patients were assigned
DDF Grade III (N = 136).
Algorithm by Johansen et al. (Figure 2B)
The initial criterion for evaluation of DDF was e’ < 9 cm/s
by pulsed-wave tissue Doppler imaging. If a patient had an
e’ below this, three criteria had to be evaluated: (i) E/A-
ratio > 2.0, (ii) LAVI ≥34 ml/m2 and (iii) E/e’-ratio ≥ 13
by pulsed-wave tissue Doppler imaging. If none of the
above were positive, patients were assigned DDF Grade I
(mild DDF; N = 276). If one criterion was positive, patients
were assigned DDF Grade II (moderate DDF; N = 183). If
two or three of the criteria were positive, patients were
assigned DDF Grade III (severe DDF; N = 186).
Figure 1 Study population. Flowchart showing the inclusion of patients eligible for grading of diastolic dysfunction by the two algorithms. HFrEF, heart
failure with reduced ejection fraction.
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Figure 2 Flowcharts of algorithms for grading of diastolic dysfunction.Study population divided into categories of diastolic dysfunction by Nagueh et al.
algorithm (A) and Johansen et al. algorithm (B). E, peak transmitral early diastolic inflow velocity; e’, peak early diastolic mitral annular velocity; E/A,
ratio between peak transmitral early and late diastolic inflow velocity; E/e’, ratio between peak transmitral early diastolic inflow velocity and peak early
diastolic mitral annular velocity; TR, tricuspid regurgitation; LAVI, left atrial volume index; LAP, left atrial pressure; cTDI, color tissue Doppler imaging;
pwTDI, pulsed-wave tissue Doppler imaging; DDF, diastolic dysfunction.
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Speckle tracking echocardiography
Two-dimensional speckle tracking analysis was performed in
the apical two-chamber, three-chamber, and four-chamber
views with an average of 74 frames per second (standard de-
viation: 18 frames per second). A region of interest (ROI) was
defined by a semiautomated function that traced the endo-
cardial border at end systole after placing three samples at
the LV base and apex. The detected ROI was visually con-
firmed by the responsible investigator and, if necessary, the
investigator manually modified the ROI to ensure correct
tracking of the bright coherent speckles. A satisfactory track-
ing had to cover the entire cardiac wall from the endocar-
dium to the myoepicardial border. Furthermore, visible
motion of the speckles had to be present. In cases of poor
tracking, the ROI was manually readjusted. Segments were
excluded when they did not fulfill these criteria or were com-
promised by shadows or artifacts. GLS was assessed as the
average value obtained from from the three apical projec-
tions. If speckle tracking could not be obtained from a cham-
ber view, GLS was averaged from the two remaining views
(total four-chamber view: 614; two-chamber view: 619; and
three-chamber view: 606).
Statistics
All statistical analyses were made using STATA version SE 13.1
(StataCorp, College Station, Texas). P < 0.05 in two-sided
tests were regarded significant. Concordance between the
two algorithms for grading of DDF was assessed using Kappa
statistics (see Supporting Information, Table S1). The reclassi-
fication percentage was calculated as 100%—proportion of
agreement. According to grades of DDF, we examined base-
line characteristics in Table 1A,1B. For approximately nor-
mally distributed variables, we used linear regression
algorithms to calculate P for trend, with the exception of sys-
tolic and diastolic blood pressure that were non-Gaussian dis-
tributed. For these variables, we used Cuzick’s nonparametric
test for trend.14 We performed Cox proportional hazards re-
gression algorithms yielding hazard ratios (HRs) with 95%
confidence intervals (CIs) for grades of DDF (Table 2). Accord-
ingly, we constructed survival curves using the Kaplan–Meier
method (Figure 3A–B). Furthermore, a sensitivity analysis was
carried out where patients categorized as ‘normal’ by
Johansen et al. were used as reference group in our survival
models. We examined if mitral valve insufficiency modified
the association between DDF and outcome and conducted a
sensitivity analysis in which the subset of the population with
mitral valve disease were stratified according to mild and
moderate/severe insufficiency. The prognostic performance
of the two DDF grading algorithms was assessed using
Harrell’s C-statistics. The performance for individual parame-
ters of the two algorithms was tested (Table 3). The three
strongest single parameters, assessed as the highest C-
statistics, were combined to determine the greatest prognos-
tic performance. Additionally, the algorithms were compared
to see if one was statistically stronger than the other using
the somersd method.
Results
Diastolic dysfunction grading
The study population (N = 645) was graded according to two
DDF algorithms: Nagueh et al. (Figure 2A) and Johansen et al.
(Figure 2B). When examining the discrepancy for grading of
DDF in the two algorithms (see Supporting Information Table
S1), the Kappa coefficient was 0.48 and the concordance was
regarded as moderate. The reclassification rate was 33%.
Baseline characteristics according to grades of DDF are
displayed in Table 1A–B. Increasing grades of DDF were asso-
ciated with higher age and mitral valve insufficiency in both
algorithms. In the algorithm by Nagueh et al., increasing
grades of DDF were associated with higher resting heart rate,
whereas in the algorithm by Johansen et al., the proportion
of male patients and a history of coronary revascularization
increased with grades of DDF. All echocardiographic parame-
ters differed across grades of DDF in both algorithms.
Nagueh et al.
The algorithm by Nagueh et al. yielded significant prognostic
information on all-cause mortality (Log-rank P < 0.001;
Figure 3A). When using DDF Grade I as reference, patients
assigned to Grade II (HR 2.02, 95% CI, 1.24–3.31, P = 0.005)
and Grade III (HR 2.09, 95% CI, 1.32–3.31, P = 0.002; Table
2) had an approximate two-fold increased risk of the end-
point. However, no significant difference was observed for
Grade II vs. Grade III (HR 1.04, 95% CI, 0.60–1.77, P = 0.90).
When restricting the analysis to the subset of patients with
mitral valve disease, stratified according to mild and
moderate/severe insufficiency, no significant associations
were found (see Supporting Information Table S2A–B).
Johansen et al.
The Johansen et al. algorithm displayed a significant log-rank
association for all-cause mortality (Log-rank P < 0.005; Figure
3B). When using Grade I as reference, only patients in Grade III
(HR 2.47, 95% CI, 1.57–3.87, P < 0.001; Table 2) had a signifi-
cantly increased risk of the endpoint, whereas the risk
remained nonsignificant for Grade II (HR 1.09, 95% CI, 0.63–
1.90, P = 0.76). As opposed to Nagueh et al., a significant differ-
ence was observed when comparing Johansen et al. Grade II
vs. Grade III (HR 2.26, 95% CI, 1.35–3.77, P = 0.002). In sensitiv-
ity analyses where patients with no DDF were used as
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reference group, the risk of the endpoint increased incremen-
tally, such that patients in DDF Grade III had a significantly in-
creased risk of the end point (HR 2.92, 95% CI, 1.61–5.30, P<
0.001). In patients with mild mitral valve insufficiency, patients
in Grade III had a significantly increased risk of the endpoint
compared with Grade II (HR 2.81, 95% CI, 1.02–7.96, P =
0.045) (see Supporting Information Table S2A–B).
Prognostic performance
We found no difference in prognostic performance between
the two algorithms (C-statistics 0.604 vs 0.623, P = 0.244).
Additionally, prognostic performance was assessed for all di-
astolic parameters in the algorithms, yielding C-statistics
ranging from 0.585 (E-wave) to 0.644 (E/e’) (Table 3). When
combining the three most powerful diastolic parameters (E/
e’, TR velocity and E/A-ratio), as assessed by the highest
C-statistics, the prognostic performance decreased to C-
statistics of 0.634, although this was not statistically signifi-
cant (P = 0.478). When GLS was added to the single strongest
and the three strongest combined parameters, the prognos-
tic performance increased significantly (Model 2 vs. 1: C-
statistics 0.721 vs. 0.644, P = 0.018; Model 6 vs. 5: C-statistics
0.705 vs. 0.634, P = 0.028; Table 3). We also examined
LVEF (C-statistics 0.687), however, no additional prognostic
Table 1A Baseline characteristics according to diastolic dysfunction grades by Nagueh et al.
I II III
DDF grades Nagueh et al. (N = 407) (N = 102) (N = 136) P trend
Clinical
Age, years 67 ± 11 71 ± 10 67 ± 11 0.006
Heart rate, bpm 72 ± 13 74 ± 16 75 ± 15 0.016
Male, n (%) 290 (71%) 66 (65%) 107 (79%) 0.056
BMI, kg/m2 26 ± 5 26 ± 5 27 ± 5 0.33
NIDDM, n (%) 37 (9%) 15 (15%) 15 (11%) 0.24
IDDM, n (%) 14 (3%) 1 (1%) 3 (2%) 0.36
Total cholesterol, mmol/L 4.5 ± 1.2 4.4 ± 1.1 4.3 ± 1.1 0.058
Mean arterial pressure, mmHg 94 ± 13 93 ± 14 91 ± 14 0.15
Systolic blood pressure, mmHg 130 (120, 140) 130 (120, 150) 130 (110, 140) 0.12
Diastolic blood pressure, mmHg 80 (60, 80) 73 (60, 80) 70 (60, 80) 0.30
Hypertension, n (%) 64 (16%) 17 (17%) 19 (14%) 0.83
History of MI, n (%) 215 (53%) 43 (42%) 67 (49%) 0.15
Angina Pectoris, n (%) 96 (24%) 27 (26%) 32 (24%) 0.82
PTCA, n (%) 137 (34%) 34 (33%) 34 (25%) 0.16
CABG, n (%) 74 (18%) 21 (21%) 33 (24%) 0.30
Ischemic cardiomyopathy, n (%) 256 (63%) 58 (57%) 82 (60%) 0.51
No. with mitral insufficiency, n (%) 106 (26%) 52 (51%) 76 (56%) <0.001
mild, n (%) 96 (91%) 39 (75%) 48 (63%)
moderate, n (%) 9 (9%) 12 (23%) 25 (33%)
severe, n (%) 1 (1%) 1 (2%) 3 (4%)
Medication
RAS blockade, n (%) 313 (77%) 79 (77%) 113 (83%) 0.31
Beta blockers, n (%) 259 (64%) 62 (61%) 93 (68%) 0.45
Spironolactone, n (%) 60 (15%) 18 (18%) 19 (14%) 0.71
Diuretics, n (%) 202 (50%) 52 (51%) 72 (53%) 0.80
Anticoagulants, n (%) 66 (16%) 16 (16%) 31 (23%) 0.19
Antiarrhythmics, n (%) 20 (5%) 3 (3%) 9 (7%) 0.43
Calcium channel blockers, n (%) 4 (1%) 0 2 (1%) 0.50
Echocardiography
LV ejection fraction, % 29 ± 9 27 ± 10 22 ± 8 <0.001
LV mass index, g/m2 112 ± 38 135 ± 42 124 ± 32 <0.001
E, m/s 0.6 ± 0.2 0.9 ± 0.3 1.0 ± 0.3 <0.001
A, m/s 0.8 ± 0.2 0.9 ± 0.3 0.4 ± 0.1 <0.001
e’, cm/s 0.6 ± 0.2 0.5 ± 0.1 0.6 ± 0.2 <0.001
Deceleration time, ms 212 ± 85 196 ± 86 149 ± 46 <0.001
E/e’ 11.4 ± 3.9 18.5 ± 5.7 19.1 ± 7.6 <0.001
E/A 0.9 ± 0.3 1.2 ± 0.4 3.1 ± 1.0 <0.001
TR velocity, m/s 2.3 ± 1.0 2.9 ± 1.2 2.9 ± 0.5 <0.001
Left atrial volume index, mL/m2 23.9 ± 7.5 37.4 ± 11.6 35.9 ± 11.5 <0.001
Max. left atrial volume index, mL/m2 26.1 ± 9.6 40.4 ± 16.1 37.2 ± 13.9 <0.001
Min. left atrial volume index, mL/m2 15.8 ± 7.4 27.7 ± 13.5 29.1 ± 12.9 <0.001
TAPSE, m/s 2.0 ± 0.5 2.0 ± 0.6 1.7 ± 0.6 <0.001
Global longitudinal strain, % 10.2 ± 3.2 9.1 ± 3.2 7.3 ± 2.5 <0.001
A, peak late diastolic transmitral velocity; BMI, body mass index; CABG, coronary artery bypass graft; DDF, diastolic dysfunction; E, peak
early diastolic transmitral velocity; e’, peak early diastolic annular mitral velocity; IDDM, insulin dependent diabetes mellitus; LV, left ven-
tricular; MI, myocardial infarction; NIDDM, non-insulin dependent diabetes mellitus; PTCA, percutaneous transluminal coronary angio-
plasty; RAS, Renin-Angiotensin system; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.
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information was found when it was added to diastolic param-
eters. In a sensitivity analysis, where patients classified as
‘normal’ by Johansen et al. were included, no significant dif-
ference between the algorithms by Johansen and Nagueh
were found (C-statistics 0.627 vs. 0.614, P = 0.634).
Discussion
In this study, we demonstrate that grading of DDF, according
to two contemporary algorithms, provides prognostic infor-
mation in patients with HFrEF. Furthermore, we show that
GLS potentially contributes incremental information on prog-
nosis when added to DDF grading in patients with HFrEF. Only
scarce information exists on the role of DDF in HFrEF, and to
the authors’ knowledge, this is the first study to compare the
prognostic potential of two contemporary DDF algorithms in
a large cohort of HFrEF patients.4
We demonstrated that increasing grades of DDF were asso-
ciated with higher risk of all-cause mortality in patients with
HFrEF. This indicates that although patients with HFrEF have
decreased myocardial contractility, the addition of more im-
paired diastolic function may still lead to a worse prognosis.
We found that the algorithm by Johansen et al. provided a
more equal distribution of patients across grades of DDF as
Table 1B Baseline characteristics according to diastolic dysfunction grades by Johansen et al.
I II III
DDF grades Johansen et al. (N = 276) (N = 183) (N = 186) P trend
Clinical
Age, years 66 ± 11 68 ± 11 69 ± 11 0.013
Heart rate, bpm 72 ± 14 72 ± 13 74 ± 16 0.15
Male, n (%) 200 (72%) 119 (65%) 144 (77%) 0.029
Body mass index, kg/m2 27 ± 4 26 ± 6 26 ± 5 0.77
NIDDM, n (%) 27 (10%) 13 (7%) 27 (15%) 0.060
IDDM, n (%) 11 (4%) 2 (1%) 5 (3%) 0.18
Total cholesterol, mmol/L 4.5 ± 1.2 4.3 ± 1.1 4.4 ± 1.1 0.13
Mean arterial pressure, mmHg 94 ± 13 93 ± 13 92 ± 14 0.49
Systolic blood pressure, mmHg 130 (120, 140) 130 (115, 150) 130 (110, 145) 0.84
Diastolic blood pressure, mmHg 80 (65, 80) 70 (60, 80) 70 (60, 80) 0.14
Hypertension, n (%) 44 (16%) 28 (15%) 28 (15%) 0.96
History of MI, n (%) 149 (54%) 94 (51%) 82 (44%) 0.11
Angina Pectoris, n (%) 74 (27%) 37 (20%) 44 (24%) 0.27
PTCA, n (%) 101 (37%) 63 (34%) 41 (22%) 0.003
CABG, n (%) 48 (17%) 30 (16%) 50 (27%) 0.017
Ischemic cardiomyopathy, n (%) 178 (64%) 110 (60%) 108 (58%) 0.35
No. with mitral insufficiency, n (%) 62 (22%) 74 (40%) 98 (53%) 0.006
mild, n (%) 57 (92%) 60 (81%) 66 (67%)
moderate, n (%) 5 (8%) 12 (16%) 29 (30%)
severe, n (%) 0 2 (1%) 3 (2%)
Medication
RAS blockade, n (%) 218 (79%) 141 (77%) 146 (78%) 0.88
Beta blocker, n (%) 174 (63%) 121 (66%) 119 (64%) 0.80
Spironolactone, n (%) 44 (16%) 24 (13%) 29 (16%) 0.69
Diuretics, n (%) 129 (47%) 100 (55%) 97 (52%) 0.22
Anticoagulants, n (%) 44 (16%) 32 (17%) 37 (20%) 0.55
Antiarrhythmics, n (%) 11 (4%) 10 (5%) 11 (6%) 0.60
Calcium channel blocker, n (%) 2 (1%) 2 (1%) 2 (1%) 0.90
Echocardiography
LV ejection fraction, % 30 ± 9 26 ± 8 24 ± 9 <0.001
LV mass index, g/m2 109 ± 37 120 ± 38 130 ± 35 <0.001
E, m/s 0.6 ± 0.2 0.8 ± 0.2 1.0 ± 0.3 <0.001
A, m/s 0.8 ± 0.2 0.8 ± 0.3 0.5 ± 0.3 <0.001
e’, cm/s 0.6 ± 0.1 0.5 ± 0.2 0.5 ± 0.2 <0.001
Deceleration time, ms 213 ± 84 196 ± 80 171 ± 78 <0.001
E/e’ 9.5 ± 2.0 15.3 ± 4.7 19.7 ± 6.8 <0.001
E/A 0.8 ± 0.3 1.1 ± 0.7 2.4 ± 1.3 <0.001
TR velocity, m/s 2.3 ± 1.1 2.5 ± 0.8 2.8 ± 1.0 <0.001
Left atrial volume index, mL/m2 22.1 ± 5.8 27.7 ± 9.0 39.2 ± 11.1 <0.001
Max. left atrial volume index, mL/m2 24.4 ± 8.2 29.4 ± 11.2 41.7 ± 14.6 <0.001
Min. left atrial volume index, mL/m2 14.5 ± 6.2 18.9 ± 8.7 31.1 ± 13.2 <0.001
TAPSE, m/s 2.0 ± 0.5 2.0 ± 0.5 1.8 ± 0.6 <0.001
Global longitudinal strain, % 10.6 ± 3.3 9.2 ± 2.7 7.9 ± 3.0 <0.001
A, peak late diastolic transmitral velocity; BMI, body mass index; CABG, coronary artery bypass graft; DDF, diastolic dysfunction; E, peak
early diastolic transmitral velocity; e’, peak early diastolic annular mitral velocity; IDDM, insulin dependent diabetes mellitus; LV, left ven-
tricular; MI, myocardial infarction; NIDDM, non-insulin dependent diabetes mellitus; PTCA, percutaneous transluminal coronary angio-
plasty; RAS, Renin-Angiotensin system; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.
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compared with the algorithm by Nagueh et al. In the algorithm
by Nagueh et al., both DDF Grade II and Grade III yielded an ap-
proximate two-fold increased hazard ratio of all-cause mortal-
ity. Noteworthy, the model lacked the ability to provide
different risk estimates between DDF Grade II and Grade III
(P difference = 0.90). In the algorithm by Johansen et al., pa-
tients assigned Grade III had a significantly increased risk of
the endpoint compared with Grade II (P = 0.002). However,
the Johansen algorithm lacked the ability to clearly delineate
prognosis between Grade I and Grade II (P difference = 0.76).
Figure 3 Kaplan–Meier survival curves. Kaplan–Meier curves showing the cumulated survival of patients divided into the three different DDF grades by
Nagueh et al. (A) and Johansen et al. (B).
Table 2 Association between diastolic dysfunction algorithms by Nagueh et al. and Johansen et al. and all-cause mortality
Nagueh et al. Johansen et al.
DDF grade HR (95% CI) P value HR (95% CI) P value
I Ref. Ref.
II 2.02 (1.24–3.31) 0.005 1.09 (0.63–1.90) 0.76
III 2.09 (1.32–3.31) 0.002 2.47 (1.57–3.87) <0.001
I 0.49 (0.30–0.81) 0.005 0.92 (0.53–1.59) 0.76
II Ref. Ref.
III 1.04 (0.60–1.77) 0.90 2.26 (1.35–3.77) 0.002
I 0.47 (0.30–0.76) 0.002 0.41 (0.26–0.64) <0.001
II 0.97 (0.56–1.65) 0.90 0.44 (0.27–0.74) 0.002
III Ref. Ref.
Associations are assessed with different grades of diastolic dysfunction as reference.
CI, confidence intervals; DDF, diastolic dysfunction; HR, hazard ratio.
8 S. Hansen et al.
ESC Heart Failure (2019)
DOI: 10.1002/ehf2.12532
The guideline from 2016 by Nagueh et al. was developed
as the former guideline from 2009 and was deemed difficult
to evaluate by clinicians.8,15 Consequently, new guidelines
were published in 2016, allowing an easier approach for clini-
cians to assess DDF. Almeida et al. showed that this algorithm
contains greater specificity compared with older algorithms
of DDF, but the sensitivity of the algorithm was too low for
grading of less severe cases of DDF.16 It was proposed that
the addition of TR velocity to the 2016 guidelines by Nagueh
et al. could explain why the specificity of the guidelines
dropped.16 This parameter was not included by Johansen
et al. The TR velocity provides a measure of chronic pressure
overload in HFpEF patients, indicating why it should be useful
to characterize increased LV filling pressure in moderate to
severe DDF.17 However, TR velocity may also be affected by
lung diseases (e.g. chronic obstructive lung disease),
explaining why the specificity dropped.18 In a clinical setting,
the TR velocity gradient may sometimes be difficult to evalu-
ate, although it is more accessible in HF patients. Notewor-
thy, the algorithms acquired different entry criteria such
that Nagueh et al. used E/A, whereas Johansen et al. used
e’. Patients with HF more often suffer from mitral valve dis-
ease, which may impact correct estimation of E/A.
An important consideration is that the algorithm by
Nagueh et al. is an expert consensus statement, which is
based on empirical evidence, for example, a study demon-
strated how E/e’ was correlated with increased filling pres-
sures.8 Opposed to this, the algorithm by Johansen et al.
is based on a risk analysis of different diastolic parameters
in patients with impaired relaxation of the myocardium. This
does not necessarily mean that they correctly identify
patients with increased LV filling pressures.9 Despite the
gold standard for diagnosing DDF is timely and costly—
namely invasively assessed LV pressure measurements—
there is a need for relating these measurements to clinical
outcomes.19
When testing the prognostic strength of the individual pa-
rameters in the two algorithms, E/e’ was found to provide
the strongest prognostic information. This is in accordance
with previous studies in patients with HFrEF.20 We observed
no significant difference in terms of prognostic strength be-
tween the two algorithms (P = 0.24), indicating that both al-
gorithms contain the same prognostic performance for all-
cause mortality. The greatest prognostic performance was
observed when GLS was added to the prediction model.
Global longitudinal strain has, in numerous studies, been
found to be a better predictor of cardiovascular outcome
than any other single echocardiographic parameter.21,22 Fur-
thermore, GLS has been shown to be a superior predictor
for all-cause mortality in HFrEF patients.23 Although GLS is
regarded to be a measure of systolic function6, we found that
GLS added incremental and novel information when assessing
prognostic performance of diastolic parameters. One study
found that GLS correlated more with invasively assessed fill-
ing pressures, as compared with the conventional echocar-
diographic parameter such as E/e’.5 Traditionally, the
cardiac cycle has been divided into systole and diastole,
where LVEF has been the main determinant of systolic func-
tion, and echocardiographic parameters, such as TDI veloci-
ties and left atrial volume, have represented diastolic
function. This approach builds upon a theoretical belief in
which longitudinal deformational measurements do not nec-
essarily fit.24 Contraction of myocardial fibers during systole
affects the diastole through a coil effect, which results in
the LV quickly expanding and thereby decreasing the intra-
ventricular pressure.25 Myocardial longitudinal fibers undergo
deformational changes during the entirety of this process,
explaining why GLS may be regarded as both a determinant
of systolic and diastolic function. Recent studies have also
shown that in patients with HFpEF, GLS may be significantly
decreased, although systolic function assessed by LVEF is
maintained.6
Study limitations
The echocardiographic examination was performed within 1
year of first arrival and was for some patients relatively long,
although the vast majority had the examination close to ad-
mittance (median: 30 before admittance; interquartile range:
6 to 56 days before admittance). Ideally, the echocardio-
graphic examination was performed on the day of admittance
to the clinic, such that it reflected the patients’ current LV
status.
Table 3 Prognostic performance, assessed as C-statistics, for dia-
stolic parameters included in the grading algorithms by Nagueh
et al. and Johansen et al.
C-statistics P value
Single parameters
E/A 0.602
E/e’ 0.644
LAVI 0.598
E 0.585
TR 0.625
e’ 0.594
GLS 0.708
Combined parameters
Model 1: E/e’ 0.644
Model 2: E/e’ + GLS 0.721 0.018*
Model 3: E/e’ + TR 0.644
Model 4: E/e’ + TR + GLS 0.705 0.060†
Model 5: E/e’ + TR + E/A 0.634
Model 6: E/e’ + TR + E/A + GLS 0.705 0.028‡
*Difference between Models 1 and 2.
†Difference between Models 3 and 4.
‡Difference between Models 5 and 6.
A, peak late diastolic transmitral velocity; E, peak early diastolic
transmitral velocity; e’, peak early diastolic mitral annular velocity;
GLS, global longitudinal strain; LAVI, left atrial volume index; TR,
tricuspid regurgitation velocity.
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The algorithm by Johansen et al. for grading of DDF is con-
structed for all patients regardless of LVEF, whereas the algo-
rithm used by Nagueh et al. is specifically made for patients
with a reduced LVEF. Therefore, HFrEF patients in the algo-
rithm by Johansen et al. could be assigned normal diastolic
function, which was not the case in the algorithm by Nagueh
et al. In a clinical setting, it may be easier to evaluate DDF if
only one algorithm is to be applied. The two algorithms ap-
plied different cut-off levels for E/e’ (13 and 14, respectively),
which may be regarded as misleading as the aim for this pa-
rameter in both algorithms is to determine increased left
atrial pressure. It is a limitation that the study cohort was re-
duced from 1 065 to 645 patients, as the ideal goal of an al-
gorithm to assess DDF must be to make it applicable to
most patients with HFrEF. In the presence of regional varia-
tions in wall thickness or asymmetric ventricles caused by hy-
pertrophy or dilatation, assessment of LV mass by the
Devereux formula may be inaccurate.10 Similarly, regional
wall motion abnormalities may affect estimation of LVEF
when using Simpson’s biplane method.
Conclusions
We demonstrated that evaluation of DDF adds prognostic
value in HFrEF patients when applying two contemporary
DDF algorithms: Nagueh et al. and Johansen et al. Further-
more, we found that GLS could offer a novel addition to
DDF algorithms, although larger and future studies are re-
quired to confirm this finding.
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